182 related articles for article (PubMed ID: 32476131)
1. Three-dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding.
Yoshizawa T; Hong SM; Jung D; Noë M; Kiemen A; Wu PH; Wirtz D; Hruban RH; Wood LD; Oshima K
J Pathol; 2020 Aug; 251(4):400-410. PubMed ID: 32476131
[TBL] [Abstract][Full Text] [Related]
2. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
[TBL] [Abstract][Full Text] [Related]
3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
[TBL] [Abstract][Full Text] [Related]
5. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
6. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression.
Yu TH; Yuan RH; Chen YL; Yang WC; Hsu HC; Jeng YM
Mod Pathol; 2011 Jun; 24(6):810-9. PubMed ID: 21423153
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of snail expression in hilar cholangiocarcinoma.
Kong D; Liang J; Li R; Liu S; Wang J; Zhang K; Chen D
Braz J Med Biol Res; 2012 Jul; 45(7):617-24. PubMed ID: 22570087
[TBL] [Abstract][Full Text] [Related]
8. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.
Hooper JE; Morgan TK; Grompe M; Sheppard BC; Troxell ML; Corless CL; Streeter PR
Hum Pathol; 2012 Oct; 43(10):1583-9. PubMed ID: 22406361
[TBL] [Abstract][Full Text] [Related]
9. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
10. The significance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in differentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis.
Dechaphunkul A; Kanngurn S; Dechsukhum C; Tanutit P; Khow-Ean U; Sunpaweravong P
J Med Assoc Thai; 2010 May; 93(5):523-8. PubMed ID: 20524437
[TBL] [Abstract][Full Text] [Related]
11. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
Akita M; Fujikura K; Ajiki T; Fukumoto T; Otani K; Azuma T; Itoh T; Ku Y; Zen Y
Mod Pathol; 2017 Jul; 30(7):986-997. PubMed ID: 28338651
[TBL] [Abstract][Full Text] [Related]
12. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
14. Impact of tumour budding grade in 310 patients who underwent surgical resection for extrahepatic cholangiocarcinoma.
Ogino M; Nakanishi Y; Mitsuhashi T; Hatanaka Y; Amano T; Marukawa K; Nitta T; Ueno T; Ono M; Kuwabara S; Yamada T; Hirano S
Histopathology; 2019 May; 74(6):861-872. PubMed ID: 30667537
[TBL] [Abstract][Full Text] [Related]
15. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
[TBL] [Abstract][Full Text] [Related]
16. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
17. CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions.
Gütgemann I; Haas S; Berg JP; Zhou H; Büttner R; Fischer HP
Virchows Arch; 2006 Apr; 448(4):407-11. PubMed ID: 16411132
[TBL] [Abstract][Full Text] [Related]
18. Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers.
Németh Z; Szász AM; Somorácz A; Tátrai P; Németh J; Gyorffy H; Szíjártó A; Kupcsulik P; Kiss A; Schaff Z
Pathol Oncol Res; 2009 Sep; 15(3):533-9. PubMed ID: 19184677
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J
PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional analysis of perineural invasion in extrahepatic cholangiocarcinoma using tissue clearing.
Ogasawara H; Yoshizawa T; Oshima K; Ogasawara K; Kubota S; Goto S; Morohashi S; Wakiya T; Kimura N; Ishido K; Kijima H; Hakamada K
Pathol Oncol Res; 2023; 29():1611284. PubMed ID: 37425091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]